Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients
Clinical trial NCT00820547 · COMPLETED
Trial details
- NCT number
- NCT00820547
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2015-04-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.